| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.668 | 28.876 | 14.108 | 18.197 | 41.178 | 45.703 | 25.996 | 20.776 |
| Total Income - EUR | - | - | 1.673 | 28.947 | 14.228 | 18.406 | 41.275 | 45.686 | 26.094 | 20.792 |
| Total Expenses - EUR | - | - | 1.632 | 22.344 | 12.481 | 11.625 | 27.967 | 42.007 | 28.200 | 22.622 |
| Gross Profit/Loss - EUR | - | - | 41 | 6.603 | 1.747 | 6.781 | 13.308 | 3.679 | -2.105 | -1.830 |
| Net Profit/Loss - EUR | - | - | -9 | 5.735 | 1.324 | 6.337 | 12.482 | 3.252 | -2.329 | -2.038 |
| Employees | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioinvent Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 32 | 0 | 0 | 0 | 0 | 12 | 0 | 55 |
| Current Assets | - | - | 628 | 7.197 | 7.542 | 14.597 | 22.351 | 19.229 | 19.190 | 17.533 |
| Inventories | - | - | 0 | 1.946 | 5.448 | 9.577 | 12.614 | 11.882 | 8.572 | 8.040 |
| Receivables | - | - | 0 | 223 | 1.050 | 842 | 1.408 | 640 | 3.091 | 2.973 |
| Cash | - | - | 628 | 5.027 | 1.044 | 4.178 | 8.329 | 6.706 | 7.527 | 6.519 |
| Shareholders Funds | - | - | 35 | 5.769 | 6.981 | 13.186 | 19.885 | 17.222 | 14.841 | 12.720 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 626 | 1.428 | 561 | 1.411 | 2.466 | 2.019 | 4.349 | 4.867 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Bioinvent Medical Srl